Nucleix
Shiri Nathansohn has four years of work experience. In 2022, they began working as a Product Development Scientist at Nucleix Ltd. Prior to that, they were a MSc Student at The Hebrew University of Jerusalem starting in 2019, a Research Assistant at the same university starting in 2018, and a Teaching Assistant at The Hebrew University Secondary School (Leyada) - בית הספר התיכון שלי דהאוניברסיטה (לידה) starting in 2018.
Shiri Nathansohn has a Bachelor of Science in Biology/Biological Sciences, General from The Hebrew University of Jerusalem, which they obtained in 2019. Shiri is currently pursuing a Master of Science in Biotechnology at The Hebrew University of Jerusalem, which they are expected to complete in 2022. In 2020 and 2021, Shiri also attended U music collage in Jerusalem for music production.
This person is not in any offices
Nucleix
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.